Definitive Contract 75N93025C00024
Award Date
8/1/25
Potential Completion Date
7/31/27
Potential Value
$599K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
L2 Diagnostics LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Woodbridge, CT 06525, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
9
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $300,000 Small Business Innovation Research (SBIR) Phase I contract to L2 Diagnostics LLC, a for-profit limited liability company based in Woodbridge, Connecticut. The contract, a Firm Fixed Price Definitive Contract with a performance period ending on November 30, 2025, is focused on discovering and validating novel diagnostic biomarkers for malaria. The contract is set aside for total small business participation. L2...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase II contract to Luna Innovations Incorporated, a manufacturer of goods, for the development of "Innovative Oral Formulations for Anti-TB Drugs". The firm-fixed-price contract, with a potential value of $1,499,796.00, was awarded on August 28, 2018, and is set to be completed by November 30, 2020. As a...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $3,752,224.00 cost-plus-fixed-fee delivery order contract to Leidos Biomedical Research Inc. for the testing of a tuberculosis vaccine candidate. The contract has a completion date of September 23, 2023 and was awarded on September 24, 2018. Leidos Biomedical Research Inc. is a subsidiary of the Leidos Holdings, Inc. conglomerate that provides research,...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (NIH NCI) awarded a Small Business Innovation Research (SBIR) Phase II contract to L2 Diagnostics LLC, a for-profit limited liability company, to develop predictive biomarkers for adverse reactions to prostate cancer radiotherapy. The $1,996,011.00 firm-fixed-price contract has a completion date of September 18, 2020 and is set aside for small businesses. L2 Diagnostics is a provider of goods...
This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases to Teichos Laboratories, LLC, a small business located in West Lafayette, IN. The $300,000 firm fixed price contract is for research on a novel TLR2 agonist-aluminum combination adjuvant to improve the quality and duration of the immune response. This SBIR contract was awarded under a solicitation that sought innovative...
This is a delivery order federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for $2,068,609.35 and supports the development of tuberculosis vaccines. The work will be performed at Leidos Biomedical Research facilities in Frederick, Maryland. This contract does not have a set-aside designation. Leidos...
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Luna Innovations Incorporated, a leading provider of advanced fiber optic sensing and measurement systems. The contract, valued at $224,997, is for the development of "INNOVATIVE ORAL FORMULATIONS FOR ANTI-TB DRUGS." This Firm Fixed Price contract has an ultimate completion date of August 25, 2017. Luna Innovations, a for-profit manufacturer, is...
This is a $1,486,937 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to PAI Life Sciences Inc., a self-certified small disadvantaged business. The contract is for the development of an inhaled drug combination for tuberculosis therapy under the SBIR Phase II program. Key tasks include the manufacture of spray-dried combination drugs, technical support for pharmacokinetic and...
This is a firm fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Luna Labs USA LLC, a division of Luna Innovations Incorporated. The contract, valued at $1,499,998.00, is for the development of innovative pediatric oral formulations for second-line tuberculosis drugs. This contract is set aside for small businesses. Luna Labs USA LLC, a leading provider of advanced...